𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adsorption and release properties of growth factors from biodegradable implants

✍ Scribed by Ziegler, J. ;Mayr-Wohlfart, U. ;Kessler, S. ;Breitig, D. ;Günther, K.-P.


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
581 KB
Volume
59
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The present investigation was performed to study the adsorption behavior of growth factors and their release characteristics from biodegradable implants in an in vitro study. We investigated the stability of growth factors administered on various scaffolds. We used porous tricalcium phosphate ceramics (α‐TCP), a neutralized glass‐ceramics (GB9N), a composite (polylactid/‐glycolid/GB9N), and solvent dehydrated human bone as carriers. Block shaped scaffolds (sized: 7 × 7 × 10 mm) were loaded with 5 μg of either bone morphogenetic protein (rxBMP‐4), basic fibroblast growth factor (rh‐bFGF), or vascular endothelial growth factor (rh‐VEGF) solved in 150 μL PBS. The growth factors were labeled with Iodine125 (I‐125) for detecting the adsorbed and released amount of growth factors by counting the samples for total I‐125 activity. We observed that the adsorption of these growth factors seems to depend on two different parameters: first on the nature of the tested material, and second on the growth factors on their own. The release kinetics of the growth factors from the biodegradable implants can be described as a two phase process—a very rapid release during the first hours by an elution of not adsorbed protein, followed by a specific release, which depends upon the chemical/physical interaction of the material and the growth factor used. Analyzing the eluted proteins on SDS‐PAGEs rh‐VEGF was degraded into a smaller fragment with a size of around 15 kDa, while rxBMP‐4 and rh‐bFGF showed a complete degradation into fragments smaller than 3 kDa after more than 3 days. Although this in vitro study suggests that biodegradable implants might be successfully used as carriers for osteogenic growth factors, the different release kinetics as well as the alteration of their molecular structure including loss of biological activity should be considered. © 2001 Wiley Periodicals, Inc. J Biomed Mater Res 59: 422–428, 2002


📜 SIMILAR VOLUMES


Biodegradable poly(D,L-lactide) coating
✍ Schmidmaier, G. ;Wildemann, B. ;Stemberger, A. ;Haas, N. P. ;Raschke, M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract Local application of growth factors like insulin like growth factor‐I (IGF‐I) and transforming growth factor‐beta 1 (TGF‐β1) from a biodegradable thin layer of poly(D,L‐lactide) (PDLLA) coated implants could stimulate fracture healing. A new “cold coating technique” for metallic implant

Basic fibroblast growth factor adsorptio
✍ Midy, V. ;Rey, C. ;Bres, E. ;Dard, M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

Basic fibroblast growth factor (bFGF) is well known as a potent angiogenic factor playing a crucial role in wound-healing processes. Apatitic substrates such as hydroxyapatite and carbonated apatite (CA) could be potential carriers of growth factors because of their physicochemical similarities to b

Controlled release of transforming growt
✍ Lu, Lichun ;Stamatas, Georgios N. ;Mikos, Antonios G. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 828 KB

Recombinant human transforming growth factor ␤1 (TGF-␤1) was incorporated into biodegradable microparticles of blends of poly(DL-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) at 6 ng/1 mg microparticles. Fluorescein isothiocynate labeled bovine serum albumin (FITC-BSA) was coencaps

Adsorption and release of insulin-like g
✍ Laffargue, Philippe ;Fialdes, Patrice ;Frayssinet, Patrick ;Rtaimate, Mohamed ;H 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

In order to develop bone substitutes, the design of biomaterials like calcium phosphate ceramic loaded with bone growth factor are of great interest. However, it is necessary to control the amount of growth factor adsorbed onto ceramics and the kinetics of its release. Radiolabeling of insulin-like

In vitro release of vascular endothelial
✍ Anthony Z. Faranesh; Monet T. Nastley; Cristina Perez de la Cruz; Michael F. Hal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

## Abstract A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL‐lactic‐co‐glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethy

Biological activity of recombinant human
✍ Joerg Ziegler; Dominique Anger; Frank Krummenauer; Dieter Breitig; Stefan Ficker 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## Abstract The present investigation was performed to study the bioactivity of osteoinductive and osteoproliferative growth factors after release from biocompatible bone implants. Three types of porous carriers were used in this study: hydroxyapatite, alpha tricalcium phosphate, and a neutralized